1. Academic Validation
  2. Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat

Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat

  • J Allergy Clin Immunol. 2016 Sep;138(3):934-936.e5. doi: 10.1016/j.jaci.2016.03.043.
Emel Aygören-Pürsün 1 Markus Magerl 2 Jochen Graff 3 Inmaculada Martinez-Saguer 4 Wolfhart Kreuz 4 Hilary Longhurst 5 Iman Nasr 5 Murat Bas 6 Ulrich Straßen 6 Lei Fang 7 Melanie Cornpropst 8 Sylvia Dobo 8 Phil Collis 8 William P Sheridan 8 Marcus Maurer 9
Affiliations

Affiliations

  • 1 Centre of Pediatrics III, Department of Hematology, Oncology and Hemostasis, Comprehensive Care Centre for Thrombosis and Hemostasis, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany.
  • 2 Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • 3 Institute of Clinical Pharmacology, Johann Wolfgang Goethe-University, Frankfurt, Germany.
  • 4 Haemophilia Centre Rhine Main, Frankfurt-Mörfelden, Germany.
  • 5 Department of Immunology, Barts Health NHS Trust, London, United Kingdom.
  • 6 HNO-Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
  • 7 Pharstat Inc, Durham, NC.
  • 8 BioCryst Pharmaceuticals Inc, Durham, NC.
  • 9 Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: Marcus.Maurer@charite.de.
Figures
Products